post-immunotherapy & frontline treatments for advanced nsclc
Published 5 years ago • 53 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
3:30
frontline treatment of advanced nsclc
-
3:54
pembrolizumab: new drug for advanced lung cancer
-
5:22
treatment for nsclc after progression on immunotherapy
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
5:15
lung cancer treatment
-
4:17
how does lung cancer affect the body?
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
2:33
lung cancer: post-frontline immunotherapy
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc
-
3:31
the keynote-024 precedent for advanced-nsclc treatment
-
3:47
pembrolizumab as treatment for oligometastatic nsclc
-
9:31
frontline treatment for egfr nsclc
-
44:56
advanced nsclc: refining clinical pathways in the rapidly evolving therapeutic landscape
-
0:48
chemotherapy-free immunotherapy-based treatment approaches for nsclc
-
2:30
dr. lopes on the keynote-042 results of frontline pembrolizumab in nsclc
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
31:51
lung cancer breakout: breakthrough treatments for longer life
-
7:11
immunotherapy in the frontline and as part of combinations for nsclc
-
7:21
comparative efficacy of chemoimmunotherapy v immunotherapy for 1st-line treatment of advanced nsclc
-
5:00
implications for pembrolizumab in nsclc
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc